³Ô¹ÏÍøÕ¾

Multimillion-dollar boost to medical research to support WA kids

  • Cook Government extends WA Child Research Fund (WACRF) for another four years
  • $16 million for health and medical research to help WA kids and teens
  • WACRF is co-founded by the State Government and Channel 7 Telethon Trust
  • Latest round of WACRF recipients receive $3.6 million

Respiratory disease is the main cause of hospitalisation and premature death in children with cerebral palsy, and new research being undertaken in Western Australia aims to better prevent and manage respiratory disease for these children.

Medical Research Minister Stephen Dawson announced a $16 million boost to the WA Child Research Fund (WACRF) over the next four years to provide ongoing investment in child and adolescent health and medical research.

Supported by the WACRF, Dr Noula Gibson and her team at the Child and Adolescent Health Service are developing the RESP-ACT program.

Dr Gibson has been awarded almost $600,000 in WACRF grant funding, to further expand her respiratory research – she is one of six WA researchers receiving a share of $3.6 million.

This program aims to provide early identification of respiratory disease in children with cerebral palsy and help them to live longer and healthier lives.

Under the RESP- ACT program, children will receive a comprehensive assessment and individualised healthcare plans with assistance provided by a range of specialists including speech pathologists, dentists, clinicians, and physiotherapists.

During a recent 12-month feasibility study at the Perth Children’s Hospital, the RESP-ACT program significantly reduced hospital admissions within the participant group.

The WACRF was set up by the Department of Health and Channel 7 Telethon Trust in 2012.

Since then, more than $46.6 million has been awarded to 160 projects – from developing probiotics to prevent childhood pneumonia to understanding the lifelong impact of paedatric burns on children’s health and reducing the impact of climate change on the health and wellbeing of children in WA.

Visit the for more information on the WA Child Research Fund and to see the complete list of 2023-24 recipients.

As stated by Medical Research Minister Stephen Dawson:

“The Cook Government is very pleased to announce this long-term multimillion-dollar commitment to the WACRF in the lead up to this year’s Telethon.

“The WACRF not only helps fund medical equipment, critical services and life-changing opportunities for sick, disadvantaged and vulnerable children, but also supports medical research into childhood diseases.

“The incredible work being supported by this fund is kicking goals in the medical research space – supporting medical researchers like Dr Gibson.

“This groundbreaking research work is crucial when it comes to providing Western Australian children with the best quality care now and into the future.”

WACRF recipient

Responsible entity

Activity title

Funding awarded

Dr Noula Gibson

Child and Adolescent Health Service

RESP-ACT: Boosting respiratory health for kids with cerebral palsy

$599,831

Associate Professor Shannon Simpson

Curtin University

Developing phenotypes of lung disease after preterm birth to enable a personalised approach to treatment

$597,349

Dr Ruth Thornton

The Kids Research Institute on behalf of the Centre for Child Health Research, The University of Western Australia

Blitz-OM: a slow-release anti-biofilm treatment for middle ear infections ‘glue ear’

$600,000

Associate Professor Anthony Kicic

Curtin University

GROW AERIAL – Gathering Respiratory epithelial Observations for lung Wellness in the AERIAL birth cohort

$599,135

Associate Professor Kathryn Ramsey

The Kids Research Institute on behalf of the Centre for Child Health Research, The University of Western Australia

IMPACT: Identifying Mechanisms and a Personalised Medicine Approach to Childhood Bronchiectasis Treatment

$596,838

Associate Professor Rishi Kotecha

Curtin University

Novel therapeutic strategies to improve the outcome for infants with acute lymphoblastic leukaemia

$599,772

/Public Release. View in full .